Introduction

A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
attention has been devoted to investigating tau in animals. Like Aß, there is a growing realization that pre-fibrillar aggregates of tau may be most culpable in AD (Hoover et al. , 2010 , Zempel et al. , 2010 .
A major still unresolved issue is the relative role of "loss" versus "gain" of function in mediating the actions of Aß and tau in AD. Thus tau and Aß may have physiological roles that are usurped when these proteins aggregate or get misprocessed leading to loss of function in addition to the more widely accepted view that abnormally aggregated proteins interact with novel targets to cause a toxic "gain" in function.
In addition to Aß and tau pathology, key factors influencing the onset and progression of AD including ageing, cerebrovascular dysfunction, pro-inflammatory, and cellular and behavioural stress mechanisms have been the focus of research. Such factors are likely to promote or trigger Aß and tau pathogenic mechanisms but may also interact as additive, independent causes of dementia (Bishop et al. , 2010 , Pimplikar et al. , 2010 .
In structural terms synaptic loss rather than frank neurodegeneration is more relevant to decline of cognitive and other functions in clinical dementia. Thus, understanding the relationship between pathological factors such as Aß and tau and disruption of synapses is of paramount importance. Given the early loss of glutamatergic neurons in AD in vulnerable pathways such as the medial temporal lobe/hippocampal network the role of irreversible excitotoxic mechanisms has long been hypothesized (Greenamyre and Young, 1989) . More recently synaptic transmission and plasticity of this transmission, before detectible loss of synapses, have been found to be disrupted in several models, increasing the possibility of targeting disease mechanisms at a potentially reversible stage. Interestingly, Aß
accumulates relatively selectively at certain (Deshpande et al. , 2009) and is released at synapses in a use-dependent manner (Bordji et al. , 2010 , Hoey et al. , 2009 ). Most investigators to date have reported that acute exogenous application of sub-micromolar concentrations of Aß has little or no acute effects on AMPA receptormediated transmission. However, a possible physiological role of sub-nanomolar concentrations of endogenous rodent Aß in the facilitation of activity-dependent presynaptic vesicular release of glutamate was reported recently (Abramov et al. , 2009 ). Thus, lowering extracellular concentration of Aß at cultured hippocampal neurons reduced synaptic facilitation whereas inhibition of Aß metabolism caused a rapid increase in the frequency, but not amplitude, of AMPA receptor-mediated miniature EPSCs. The increase in release probability was associated with reduced paired-pulse facilitation such that excitatory synapses behaved like low-pass filters, facilitating low frequency activation of AMPA receptors in hippocampal slices. How this presynaptic facilitatory action relates to the putative negative feedback postsynaptic actions of endogenously-generated human Aß (Hsieh et al. , 2006 , Wei et al. , 2010 is not clear. If confirmed, caution will be needed in the use of anti-Aß therapies that might interfere with such physiological processes.
AMPA ( -amino
The loss of AMPA-receptor-mediated transmission in AD is likely to be at least partly caused by the generation of non-physiological assemblies of Aß. Li et al (2009) reported that cell-derived oligomeric human Aß acutely increased extracellular glutamate concentrataion in hippocampal slices. Whereas low nanomolar concentrations of these oligomers reduced the amplitude of AMPA receptor-mediated (Cerpa et al. , 2010 , Kessels et al. , 2010 , Ronicke et al. , 2010 ).
Although there are many possible explanations, Li et al (2009) found that an agent that blocks AMPA receptor desensitization, cylothiazide, prevented the oligomerinduced reduction of EPSCs, consistent with Aß acting by inhibiting glutamate uptake. Indeed, micromolar concentrations of synthetic Aß1-42 oligomers, especially in the presence of cyclothiazide, apparently can rapidly trigger AMPA receptordependent inward currents and delayed neurodegeneration in cultured cortical neurons (Alberdi et al. , 2010) . Taken together, these findings indicate that agents designed to directly boost AMPA receptor function in AD may have a relatively narrow therapeutic window.
Evidence for a more direct interaction between AMPA receptors and Aß oligomers was provided in a recent paper that confirmed the ability of high nanomolar concentrations of Aß oligomers to preferentially bind to excitatory dendritic spines in cultured hippocampal neurons Liu et al (2010) who reported that A C C E P T E D M A N U S C R I P T
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micromolar Aß oligomers induced a protein kinase C-dependent phosphorylation and internalization of these receptors (Liu et al. , 2010 The authors provided evidence that these morphological, molecular, cellular and behavioural deficits are due to a reversible oxidative stress-induced increase in caspase-3 cleavage of calcineurin (thereby increasing its activity), which in turn promotes dephosphorylation of postsynaptic AMPA receptors thereby triggering their internalization.
There is growing evidence that tau may mediate synaptic dysfunction in AD.
Thus, accumulation of mis-sorted hyperphosphorylated tau in dendritic spines has been implicated in disruption of AMPA (and NMDA) receptor trafficking and anchoring (Hoover et al., 2010) . Indeed micromolar Aß oligomers, like glutamate, can cause rapid mis-sorting of several proteins including phosphorylated tau into dendrites and local depletion of mitochondria and subsequent loss of spines in cultured hippocampal neurons (Zempel et al., 2010) . Furthermore, prolonged exposure to soluble AD brain extracts that contain nanomolar Aß oligomers cause synaptic loss in a tau-dependent manner (Jin et al. , 2011) . Interestingly, cortical spine loss associated
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with soluble Aß was detected in vivo in hAPP-tau transgenic mice with confocal imaging only in spines that accumulated hyperphosphorylated tau (Bittner et al. , 2010) . Furthermore, abnormal increased hippocampal excitatory synaptic transmission in hAPP transgenic mice is absent when these mice are crossed with taudeficient mice (Roberson et al. , 2011 ).
An emerging view is that the most pathologically relevant concentrations and assembly states of Aß acutely can indirectly increase extracellular glutamate levels with relatively subtle immediate effects on AMPA receptor-mediated transmission.
Prolonged exposure or higher acute concentrations of Aß oligomers cause AMPA receptor endocytosis and may consequently trigger synaptic loss, probably as a result of non-apoptotic activation of certain caspases.
NMDA (N-methyl-D-aspartate) receptor-mediated transmission (see also
Fig. 2)
An Aß-mediated increase in extracellular glutamate levels would be expected to modulate NMDA receptor-as well as AMPA receptor-mediated transmission. Indeed, Li et al. (2009) reported that in hippocampal slices the peak amplitude of NMDA receptor-mediated EPSCs was rapidly reduced by low nanomolar cell-derived Aß oligomers but the total charge transfer was not significantly affected due to prolongation of the EPSC. Interestingly, the relative contribution of different NMDA receptors to transmission was changed. Thus pharmacological evidence was provided that following Aß oligomer treatment the relative contribution of GluN2B (also known as NR2B) subunit-containing NMDA receptors, and extrasynaptic NMDA receptors increased markedly. In a separate study (Cerpa et al., 2010) , a high nanomolar oligomer-enriched preparation of synthetic Aß1-42 also caused a rapid and
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relatively large reduction in the amplitude of evoked NMDA receptor-mediated EPSCs in hippocampal slices. However these authors did not report the kinetics of the currents or the total charge transfer. In contrast, in cultured cortical neurons micromolar Aß1-42 oligomers either rapidly triggered inward currents that were NMDA receptor-dependent (Alberdi et al. , 2010) or had no significant effect on NMDA-evoked currents (Gu et al., 2009 (Goussakov et al., 2010) . A putative mechanism proposed for this synergism is formation of a complex between GluN2B subunits and ryanodine receptors (Seeber et al. , 2004) .
Indeed high nanomolar Aß oligomer-induced delayed reduction in AMPA receptor-mediated transmission and synaptic pruning in hippocampal neurons is also GluN2B-dependent, being ameliorated by selective antagonists for NMDA receptors containing this subunit (Ronicke et al., 2010) . This deleterious effect was related to a GluN2B-dependent translocation to the nucleus of a signaling protein termed Jacob and subsequent activation of the CREB shut-off pathway. Interestingly, low nanomolar concentration of cell-derived Aß oligomers also increase the activity of a tyrosine phosphatase, striatal-enriched phosphatase 61 (STEP) which promotes the endocytosis of GluN2B-containing NMDA receptors in cortical slices via dephosphorylation of the Src kinase Fyn and GluN2B at Y1472 (Kurup et al., 2010) .
Furthermore, genetic knockout of STEP prevented a reduction in hippocampal
synaptic GluN2 content and cognitive impairment in hAPP and hAPP-tau transgenic mice .
Remarkably, although tau, the other key player in AD pathology, is normally considered to be principally involved in the stable assembly of microtubules, a key role in regulating the phosphorylation of GluN2B subunits by the Src kinase Fyn has been reported (Ittner et al., 2010) . Tau However, evidence of a more direct link between mGlu receptors and Aß's synaptic actions was recently reported (Renner et al., 2010) . Using antibodies Renner et al.
(2010) discovered that relatively low nanomolar Aß oligomer binding to cultured hippocampal neuron synapses was dependent on mGlu5 but not AMPA receptors and confirmed a dependence on NMDA receptors and cellular prion protein, which were non-additive contributors to binding. They found that A 1-42 oligomers rapidly bind β to neuronal membrane, diffuse laterally and then gradually accumulate in clusters at excitatory synapses. These clusters altered the distribution and reduced the mobility of associated mGlu5 receptors. The slower lateral mobility of these receptors impaired their exchange between synaptic and extrasynaptic locations, which in turn increased synaptic mGlu5 receptors. Consequently, aberrant activation of mGlu5 receptors in ectopic signaling platforms promoted an increased intracellular Ca 2+ and the removal
of NMDA receptors from synapses (Renner et al., 2010) . mGlu5 and NMDA receptors are closely associated signaling partners, e.g. activation of mGlu5 receptors potentiates NMDA receptor function (Niswender and Conn, 2010) and the authors concluded that NMDA receptor-dependent synaptic effects are downstream of mGlu5 receptors.
Interestingly, by using astrocyte-rich cultures, Casley et al. (Casley et al. , 2009) found that A can also enhance the magnitude of the intracellular calcium β mobilization induced by the mGlu5 receptor activation. Whether or not similar mechanisms to those described for receptor clustering in neurons applies to glia requires further study.
5
Plasticity of AMPA receptor-mediated synaptic transmission (see also Fig. 
4)
Synaptic plasticity mechanisms underlie cognitive functions including memory, and are exquisitely sensitive to Aß oligomers, which potently enhance long-term depression (LTD) and inhibit long-term potentiation (LTP) (Li et al., 2009) , Liu et al., 2010 .
Moreover, a role for GSK3 was implicated in Aß-mediated inhibition of baseline and chemically -induced rapid membrane insertion of AMPA receptors in cultured hippocampal neuron spines using the a selective inhibitor (Rui et al., 2010) .
Interestingly, spines associated with mitochondria, and showing surface accumulation of AMPA receptors, tended to be more resistant to A -mediated inhibition of AMPA β receptor trafficking.
Inhibitors of GSK3 also can prevent the inhibition of high frequency stimulation-induced LTP in hAPP transgenic mice (Ma et al., 2010) . Furthermore, genetic deletion of FK506-binding protein 12 prevented disruption of LTP by Aß1-42
oligomers. The protective effect of these interventions was attributed by these authors to reversing Aß-mediated inhibition of activity of the Ser/Thr protein kinase mammalian target of rapamycin (mTOR) signaling pathway. Consistent with this, the neurotrophin BDNF, which acts through trkB receptors partly via the mTOR signaling pathway, is critical for synaptic AMPA receptor expression and delivery (Li and Keifer, 2008) and has been found to prevent A 1-42-mediated reduction of LTP in β hippocampal slices, and LTP-associated CaMKII activation and AMPA receptor phosphorylation at a CaMKII-dependent site (Zeng et al., 2010) .
Further support for a key role of GSK3 in mediating disruption of synaptic
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plasticity in hippocampal slices was recently reported by Shipton et al, (2011) . These authors implicated downstream GSK3-mediated phosphorylation of tau since the deficit in LTP was not triggered in slices from tau deficient mice. Remarkably, the acute inhibition of LTP by Aß in hippocampal slices can be reversed by treatment with a selective GSK3 inhibitor even after the application of Aß (Jo et al., 2011) . In a very elegant set of experiments strong evidence was provided that the disruption of LTP by Aß was caused by relatively specific activation of caspase 3, which in turn cleaved Akt, a key negative regulator of GSK3 kinase activity (Jo et al., 2011) .
Additional, more indirect, mechanisms have been hypothesized to mediate the inhibition of NMDA receptor-dependent LTP by Aß. For example, a reduction in synaptic NMDA receptor function has been proposed to underlie this impairment of plasticity (Cisse et al., 2011) . Aß oligomers were found to potently bind to the postsynaptic protein tyrosine kinase EphB2, which in turn was internalized and cleaved. Loss of EphB2, which regulates NMDA receptor trafficking, triggered the removal of synaptic NMDA receptors. Consistent with the hypothesis, the impairment of LTP by Aß and similar LTP deficits and learning impairments in hAPP transgenic mice were ameliorated by genetic overexpression of EphB2. Given the potential redundancy of synaptic NMDA receptors it will be important to determine if the observed reduction in NMDA receptors was sufficient on its own to disrupt synaptic plasticity. Another related putative mechanism for the inhibition of LTP by Aß involves increased activation of STEP with consequent endocytosis of GluN2B subunits (Kurup et al., 2010) . Genetic knockout of STEP enhanced LTP in hAPP-tau transgenic mice . However, removal of STEP in controls also enhanced LTP and it was unclear if there was an LTP deficit in the transgenic mice.
Given the ability of the clinically used NMDA receptor antagonist memantine to Future studies are likely to probe more deeply into the relationship between rapid and delayed effects of Aß at pre-and post-synaptic sites on glutamatergic synapses. Already it is known that Aß can be released in an activity-dependent manner from both axons and dendrites to disrupt chemically-induced structural
plasticity and initiate spine loss in hippocampal slice culture within 1-3 days (Wei et al., 2010) . Similarly, the relative importance of synaptic versus extrasynaptic glutamate receptors and their trafficking between different compartments in mediating Aß action needs to be integrated with our growing knowledge of their roles in cognitive decline in other neurodegenerative diseases such as Huntington's disease (Hardingham and Bading, 2010) . How, and at what stage, the many different neuronal and non-neuronal (e.g. glial and vascular) binding sites for Aß oligomers contribute to synaptic and non-synaptic mechanisms mediating cognitive impairment is only beginning to be understood.
Of particular interest is how behavioural factors affect Aß -induced changes in glutamate receptor function and distribution. Intriguingly, the profile of changes in synaptic plasticity observed in hAPP transgenic mice are determined by prior training in a learning task (Middei et al., 2010) . Thus, an impairment in LTP persistence was only detected in transgenic animals that had undergone water maze training.
As noted in the Introduction, glutamate receptors are not only involved in the process of A -mediated synaptic dysfunction but also play important roles in A β β production (see also Figs. 2 and 3). Recently it was reported that whereas synaptic NMDA receptor activation promotes non-amyloidogenic -secretase processing of α APP and thereby decreases A production, extrasynaptic receptor activation increases β A production β (Bordji et al., 2010 , Hoey et al., 2009 . Furthermore, activation of NMDA receptors by endogenously released glutamate in the presence of glycine can reduce intraneuronal A levels β (Tampellini et al., 2009) . Similarly group I and group II mGlu receptor subtype selective agents exert differential actions on Aß production and release (Kim et al., 2010) . These findings raise many questions such as how endogenous glutamate receptor stimulation affects neuronal A production from β Research Highlights Dementia; synaptic plasticity; long-term potentiation; long-term depression; Lglutamate receptor trafficking; learning
